Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BORN: Cord Blood vs Adult RBC Transfusions for ROP in ELGANs
NCT05100212Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2021
- Primary completion
- Jan 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood red blood cells in retinopathy of prematurity (ROP), sponsored by Policlinico Gemelli. Started Dec 2021; status: completed.
02
Drugs
umbilical cord blood red blood cells
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT05100212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05100212.